datetime,headline,summary,related,lang,source
2020-11-12 16:30:00-05:00,"Worldwide Suction Catheter Industry to 2025 - Featuring Becton, Stryker and Avanos Medical Among Others","DUBLIN, Nov. 12, 2020 /PRNewswire/ -- The ""Suction Catheter Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Product Type"" report has been added to ResearchAndMarkets.com's offering. This report is a professional and…",AVNS,en,PR Newswire
2020-11-03 10:21:00-05:00,Avanos Medical may delivered a positive earnings surprise Stock market Insights & financial analysis,"Avanos Medical announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…",AVNS,en,Stock Market Daily
2020-10-24 09:20:57-05:00,"Zacks: Analysts Anticipate Avanos Medical, Inc. (NYSE:AVNS) Will Post Earnings of $0.14 Per Share","Wall Street brokerages expect Avanos Medical, Inc. (NYSE:AVNS) to post earnings per share (EPS) of $0.14 for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Avanos Medical’s earnings, with the highest EPS estimate coming in at $0.15 and the lowest estimate coming in at $0.12. Avanos Medical posted earnings per […]",AVNS,en,Transcript Daily
2020-10-22 22:22:43-05:00,"Avanos Medical, Inc. (NYSE:AVNS) Expected to Announce Quarterly Sales of $165.90 Million","Equities research analysts expect that Avanos Medical, Inc. (NYSE:AVNS) will post sales of $165.90 million for the current quarter, according to Zacks. Three analysts have issued estimates for Avanos Medical’s earnings, with the highest sales estimate coming in at $166.20 million and the lowest estimate coming in at $165.70 million. Avanos Medical reported sales of […]",AVNS,en,US Banking News
2020-10-20 21:26:49-05:00,"Brokerages Expect Avanos Medical, Inc. (NYSE:AVNS) Will Announce Earnings of $0.14 Per Share","Equities analysts expect Avanos Medical, Inc. (NYSE:AVNS) to report earnings of $0.14 per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Avanos Medical’s earnings, with the highest EPS estimate coming in at $0.15 and the lowest estimate coming in at $0.12. Avanos Medical reported earnings of $0.30 […]",AVNS,en,US Banking News
2020-06-05 10:31:58-05:00,Avanos Medical (AVNS) Up 0.1% Since Last Earnings Report: Can It Continue?,Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,AVNS,en,Zacks Investment Research
2020-05-18 01:02:00-05:00,Here's Why You Should Retain Avanos Medical Stock for Now,"Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.",AVNS,en,Zacks Investment Research
2020-05-08 07:59:00-05:00,"Avanos Medical (AVNS) Q1 Earnings Lag Estimates, Revenues Top",Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.,AVNS,en,Zacks Investment Research
2020-05-06 07:55:07-05:00,Avanos Medical (AVNS) Lags Q1 Earnings Estimates,"Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?",AVNS,en,Zacks Investment Research
2020-04-29 06:00:00-05:00,"Avanos Medical, Inc. To Webcast Conference Call Discussing First Quarter 2020 Financial Results","ALPHARETTA, Ga., April 29, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2020 on Wednesday, May 6 at 9 a.m. ET. The company will issue a news release detailing its results…",AVNS,en,PR Newswire
2020-04-28 11:33:24-05:00,Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?,Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,AVNS,en,Zacks Investment Research
2020-04-16 15:00:00-05:00,"Avanos Medical, Inc. Changes to Virtual Meeting Format for 2020 Annual Meeting of Stockholders","ALPHARETTA, Ga., April 16, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that, due to the increasing public health risk posed by COVID-19 and in accordance with current governmental state of emergency orders, its 2020 Annual Meeting of Stockholders will be changed…",AVNS,en,PR Newswire
2020-04-06 01:48:00-05:00,Here's Why You Should Hold on to Avanos Medical Stock Now,"Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.",AVNS,en,Zacks Investment Research
2020-03-26 10:30:31-05:00,Why Is Avanos Medical (AVNS) Down 30.2% Since Last Earnings Report?,Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,AVNS,en,Zacks Investment Research
2020-03-04 00:30:00-05:00,Here's Why You Should Hold Avanos Medical (AVNS) Stock Now,Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.,AVNS,en,Zacks Investment Research
2020-02-27 09:56:00-05:00,Avanos (AVNS) Earnings and Revenues Beat Estimates in Q4,Avanos (AVNS) gains from segmental contributions in Q4.,AVNS,en,Zacks Investment Research
2020-02-25 16:14:08-05:00,"Avanos Medical, Inc. (AVNS) Q4 2019 Earnings Call Transcript | The Motley Fool","AVNS earnings call for the period ending December 31, 2019.",AVNS,en,The Motley Fool
2020-02-11 07:00:00-05:00,"Avanos Medical, Inc. To Webcast Conference Call Discussing Fourth Quarter and Full-Year 2019 Financial Results","ALPHARETTA, Ga., Feb. 11, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full-year 2019 and its 2020 outlook on Tuesday, Feb. 25 at 9 a.m. ET. The company will issue a…",AVNS,en,PR Newswire
2020-01-24 15:30:30-05:00,Avanos Medical (AVNS) Presents At JP Morgan Annual Healthcare Conference - Slideshow,"The following slide deck was published by Avanos Medical, Inc. in conjunction with this event.",AVNS,en,Seeking Alpha
2020-01-08 07:00:00-05:00,"Avanos Medical, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference","ALPHARETTA, Ga., Jan. 8, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday Jan. 15 at approximately 2 p.m. PT at the Westin St. Francis Hotel in San…",AVNS,en,PR Newswire
2019-12-30 07:00:00-05:00,Avanos Medical Appoints Michael C. Greiner as Chief Financial Officer,"ALPHARETTA, Ga., Dec. 30, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the appointment of Michael C. Greiner as senior vice president and chief financial officer, effective Jan. 1, 2020. Greiner brings to Avanos more than 20 years of experience in corporate…",AVNS,en,PR Newswire
2019-12-05 11:31:00-05:00,Why Is Avanos Medical (AVNS) Down 1.8% Since Last Earnings Report?,Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,AVNS,en,Zacks Investment Research
2019-11-13 07:00:00-05:00,"Avanos Medical, Inc. to Present at the Stifel 2019 Healthcare Conference","ALPHARETTA, Ga., Nov. 13, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the Stifel 2019 Healthcare Conference in New York City on Wednesday, Nov. 20 at approximately 8 a.m., ET. A webcast of the conference…",AVNS,en,PR Newswire
2019-11-07 13:18:43-05:00,Avanos Medical (NYSE:AVNS) Releases FY19 Earnings Guidance,"Avanos Medical (NYSE:AVNS) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $1.00-1.10 for the period, compared to the Thomson Reuters consensus estimate of $1.19. The company issued revenue guidance of +5-7% yr/yr to ~$685-698 million, compared to the consensus revenue estimate of $708.11 million. Several research analysts […]",AVNS,en,Modern Readers
2019-11-06 09:59:00-05:00,Avanos (AVNS) Earnings and Revenues Miss Estimates in Q3,Avanos (AVNS) third-quarter results benefit from higher revenues and strong segmental performance.,AVNS,en,Zacks Investment Research
2019-11-06 07:00:00-05:00,"Avanos Medical, Inc. Announces Participation in the Stephens Nashville Investment Conference","ALPHARETTA, Ga., Nov. 6, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Crawford, vice president of investor relations, will present at the Stephens Nashville Investment Conference at the Omni Nashville hotel in Nashville, TN on Wednesday, Nov. 13 at…",AVNS,en,PR Newswire
2019-11-05 09:15:05-05:00,Avanos Medical (AVNS) Q3 Earnings and Revenues Lag Estimates,"Avanos Medical (AVNS) delivered earnings and revenue surprises of -6.25% and -5.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?",AVNS,en,Zacks Investment Research
2019-11-05 07:00:00-05:00,"Avanos Medical, Inc. Announces Third Quarter 2019 Results, Completes Acquisition of Endoclear LLC","ALPHARETTA, Ga., Nov. 5, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2019 results and revised its full-year 2019 outlook. ""Our COOLIEF business delivered another quarter of double-digit growth; nevertheless, we were disappointed that our overall…",AVNS,en,PR Newswire
2019-10-29 07:00:00-05:00,"Avanos Medical, Inc. Announces Webcast of Third Quarter 2019 Financial Results Conference Call","ALPHARETTA, Ga., Oct. 29, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2019 on Tuesday, Nov. 5 at 9 a.m. ET. The company will issue a news release detailing its results…",AVNS,en,PR Newswire
2019-10-21 08:29:48-05:00,"Are Hedge Funds Right About Avanos Medical, Inc. (AVNS) ?","The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled",AVNS,en,ACI Information Group
2019-10-10 08:21:00-05:00,Avanos Medical (AVNS) Catches Eye: Stock Jumps 6.2%,"Avanos Medical (AVNS) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.",AVNS,en,Zacks Investment Research
2019-09-05 08:31:21-05:00,Avanos Medical (AVNS) Down 8.9% Since Last Earnings Report: Can It Rebound?,Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,AVNS,en,Zacks Investment Research
2019-08-27 06:29:00-05:00,"The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 26) DURECT Corporation (NASDAQ: DRRX ) Stoke Therapeutics Inc (NASDAQ: STOK ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 26) Advaxis, Inc. (NASDAQ: ADXS ) Arbutus Biopharma Corp (NASDAQ: ABUS ) ASLAN PHARMACEU/ADR (NASDAQ: ASLN ) Avanos Medical Inc (NYSE: AVNS ) Cancer Genetics Inc (NASDAQ: CGIX ) Clearside Biomedical Inc (NASDAQ: CLSD ) Elanco Animal Health Inc (NYSE: ELAN )(Bank of America downgraded the shares to Neutral) Neurometrix Inc (NASDAQ: NURO ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Tocagen Inc (NASDAQ: TOCA ) Unity Biotechnology Inc (NASDAQ: UBX ) Zafgen Inc (NASDAQ: ZFGN ) Stocks In Focus Nuvectra To Explore Strategic Options Nuvectra Corp (NASDAQ: NVTR ) announced its decision to explore strategic alternatives to …",AVNS,en,Benzinga
2019-08-22 06:18:53-05:00,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 21) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) AstraZeneca plc (NYSE: AZN )(advanced despite reporting negative results for its lung cancer drug) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Cardiovascular Systems Inc (NASDAQ: CSII ) DexCom, Inc. (NASDAQ: DXCM ) Lipocine Inc (NASDAQ: LPCN ) NextCure Inc (NASDAQ: NXTC ) Nevro Corp (NYSE: NVRO ) Novocure Ltd (NASDAQ: NVCR ) Recro Pharma Inc (NASDAQ: REPH ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 21) Abeona Therapeutics Inc (NASDAQ: ABEO ) Artelo Biosciences Inc (NASDAQ: ARTL ) Avanos Medical Inc (NYSE: AVNS ) CAN-FITE BIOPHA/S ADR (NYSE: CANF ) KemPharm Inc (NASDAQ: KMPH ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nektar Therapeutics (NASDAQ:NKT) Obalon Therapeutics Inc (NASDAQ: OBLN ) STRATA Skin Sciences Inc (NASDAQ: SSKN ) Stocks In Focus ViiV's Long-Acting HIV Drug Combo Aces Late-Stage Trial ViiV Healthcare, majority owned by GlaxoSmithKline plc (NYSE: GSK ), with Pfizer Inc.","AZN,AVNS",en,Benzinga
2019-08-07 08:10:00-05:00,"Avanos (AVNS) Q2 Earnings Beat Estimates, Revenues Miss","Avanos (AVNS) second-quarter results benefit from higher revenues, strong segmental performance and expansion in margins.",AVNS,en,Zacks Investment Research
2019-08-06 08:35:06-05:00,Avanos Medical (AVNS) Tops Q2 Earnings Estimates,"Avanos Medical (AVNS) delivered earnings and revenue surprises of 12.00% and -0.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",AVNS,en,Zacks Investment Research
2019-05-09 08:22:24-05:00,Avanos launches offer for outstanding debt,No summary available.,AVNS,en,Seeking Alpha
2019-05-08 03:51:00-05:00,"Avanos (AVNS) Q1 Earnings Miss Estimates, Revenues Beat","Avanos (AVNS) Q1 results benefit from higher revenues, strong segmental performance and expansion in margins.",AVNS,en,Zacks Investment Research
2019-05-07 22:47:09-05:00,"Avanos Medical, Inc. (AVNS) CEO Joseph Woody on Q1 2019 Results - Earnings Call Transcript",No summary available.,AVNS,en,Seeking Alpha
2019-05-07 13:24:07-05:00,"Avanos Medical, Inc. (AVNS) Q1 2019 Earnings Call Transcript","AVNS earnings call for the period ending March 31, 2019.",AVNS,en,The Motley Fool
2019-05-07 06:06:13-05:00,"Avanos Medical beats by $0.02, beats on revenue",No summary available.,AVNS,en,Seeking Alpha
2019-04-24 09:33:24-05:00,Earnings Preview: Avanos Medical (AVNS) Q1 Earnings Expected to Decline,Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,AVNS,en,Zacks Investment Research
2019-04-01 13:43:10-05:00,Avanos Killed Their Golden Goose,No summary available.,AVNS,en,Seeking Alpha
2019-02-26 15:27:07-05:00,"Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q4 2018 Results - Earnings Call Transcript",No summary available.,AVNS,en,Seeking Alpha
2019-02-26 10:15:41-05:00,"Avanos Medical, Inc. 2018 Q4 - Results - Earnings Call Slides",No summary available.,AVNS,en,Seeking Alpha
2019-02-26 07:06:55-05:00,"Avanos Medical beats by $0.11, beats on revenue",No summary available.,AVNS,en,Seeking Alpha
